Walleye Capital
PRVL

Walleye Capital’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Walleye Capital’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-15,025
Closed -$347 – 1590
2020
Q4 		$347 Buy
+15,025
New +$347 0.02% 574